Cart
sales@molnova.com
NG-52
CAS No. 212779-48-1
NG-52 ( Compound 52 )
Catalog No. M13385 CAS No. 212779-48-1
NG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | In Stock |
|
| 5MG | 144 | In Stock |
|
| 10MG | 255 | In Stock |
|
| 25MG | 489 | In Stock |
|
| 50MG | 705 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 500MG | 1971 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNG-52
-
NoteResearch use only, not for human use.
-
Brief DescriptionNG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.
-
DescriptionNG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 μM).
-
SynonymsCompound 52
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCdc28p
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number212779-48-1
-
Formula Weight346.81
-
Molecular FormulaC16H19ClN6O
-
Purity>98%(HPLC)
-
SolubilityDMSO: > 100mM
-
SMILESCC(C)N1C2=NC(NCCO)=NC(NC3=CC=CC(Cl)=C3)=C2N=C1
-
Chemical Name2-((6-((3-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)ethan-1-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.ray NS, et al. Science. 1998 Jul 24;281(5376):533-8.
molnova catalog
related products
-
LY2835219 mesylate
LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM in cell-free assays, respectively. Phase 3.
-
VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
-
Palbociclib
A potent and selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM; no inhibition for CDK2A (IC50>5 uM); inhibits MDA-MB453 cells with IC50 of 0.16 uM.
